Brief: SK Bioscience Joins Forces With Global Institutions To Advance Rotavirus Vaccine Development
09/06/2026 13:02
BRIEF-SK Bioscience Joins Forces With Global Institutions To Advance Rotavirus Vaccine Development June 9 (Reuters) - SK Bioscience Co Ltd 302440.KS:
SK BIOSCIENCE JOINS FORCES WITH GLOBAL INSTITUTIONS TO ADVANCE ROTAVIRUS VACCINE DEVELOPMENT
SK BIOSCIENCE CO - INITIATES PROCESS DEVELOPMENT FOR INJECTABLE ROTAVIRUS VACCINE CANDIDATE
SK BIOSCIENCE CO - LICENSES VACCINE TECHNOLOGY FROM U.S. CDC
Source text: ID:nPn6HMqDPa
Further company coverage: 302440.KS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SK Bioscience Co
See all newsBrief: SK Bioscience Joins Forces With Global Institutions To Advance Rotavirus Vaccine Development
Brief: SK Bioscience Files For First-In-Human Trial Of Universal Coronavirus Vaccine GBP511 Phase 1/2 Study In Australia
Novavax beats quarterly revenue estimates on milestone payment (updated)
Brief: Sk Bioscience Submits Ind For Phase 1/2 Clinical Trial Of Adjuvanted Influenza Vaccine Candidate
Brief: SK Bioscience - Wins Patent Lawsuit Against Pfizer Over Pneumococcal Vaccine